The Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg is coordinating a European Union project for research into new active compounds against Parkinson’s disease (PD).
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.